NCT07383558 Effect of Additional Sural Nerve PRF in Chronic Heel Pain
| NCT ID | NCT07383558 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diskapi Teaching and Research Hospital |
| Condition | Chronic Plantar Heel Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 48 participants in total. It began in 2025-06-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to compare the effectiveness of pulsed radiofrequency (PRF) treatment applied to the posterior tibial nerve alone versus PRF applied to both the posterior tibial and sural nerves in patients with chronic plantar heel pain. Outcomes will be assessed using the Visual Analog Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score at baseline, 1 month, and 3 months after treatment.
Eligibility Criteria
Inclusion Criteria: Age between 18 and 65 years Presence of chronic plantar heel pain Baseline VAS score \>5 Exclusion Criteria: History of foot fracture or tumor Pregnancy Coagulopathy or use of antiplatelet therapy Cognitive impairment preventing informed consent
Frequently Asked Questions
Who can join the NCT07383558 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Plantar Heel Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07383558 currently recruiting?
Yes, NCT07383558 is actively recruiting participants. Visit ClinicalTrials.gov or contact Diskapi Teaching and Research Hospital to inquire about joining.
Where is the NCT07383558 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07383558 clinical trial?
NCT07383558 is sponsored by Diskapi Teaching and Research Hospital. The trial plans to enroll 48 participants.